OVERVIEW

Nonstatin Therapy for Managing Residual Atherosclerotic Cardiovascular Disease Risk is organized by American College of Cardiology (ACC).

Date of Release: August 1, 2022
Term of Approval/Date of Expiration: July 31, 2025

Description:
The goal of this activity is for participants to be able to determine an evidence-based treatment plan that includes ensuring the optimization of statin and non-statin therapies to decrease ASCVD risk. This activity is part of the Modern Lipid Management: The Updated Medicine Cabinet grant project.

Learner Objectives:  
Upon completion of this activity, you should be able to:  
• Select appropriate patients who would benefit from the novel and emerging non-statin therapies.

Additional details will be posted as soon as information is available.

TARGET AUDIENCE

PhysicianNursingPhysician AssistantNurse Practitioners

SPECIALITIES

Cardiovascular Disease

RELATED ONLINE COURSES

Alaska Nurse Practitioners State Board required courses bundle
Jul 14, 2021 - May 23, 2025 | Webcast
State required course for Alaska
4 AMA PRA Category 1 Credit™ ...
More actions
US$440
Illinois Nurse Practitioners State Board required courses bundle
Jul 14, 2021 - Jun 22, 2025 | Webcast
State required course for Illinois
4 AMA PRA Category 1 Credit™ ...
More actions
US$470
Ohio Nurse Practitioners State Board required courses bundle
Jul 14, 2021 - Jun 22, 2025 | Webcast
State required course for Ohio
12 Contact Hours
More actions
US$470